Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BalaBioResearch Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1930394110906580992.png) BalaBio Research [@BalaBioResearch](/creator/twitter/BalaBioResearch) on x XXX followers
Created: 2025-07-14 20:46:31 UTC

$FOLD Hard to believe Amicus isn't an acquisition target at these prices. $SNY $BMRN make sense as possible targets, though BMRN would need to leverage with debt. Unless they terribly botch their launches Amicus really should be an easy XX% to XXX% gain in the coming years


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944861086592720998/c:line.svg)

**Related Topics**
[debt](/topic/debt)
[$sny](/topic/$sny)
[acquisition](/topic/acquisition)
[$fold](/topic/$fold)
[sanofi](/topic/sanofi)
[stocks healthcare](/topic/stocks-healthcare)
[$bmrn](/topic/$bmrn)

[Post Link](https://x.com/BalaBioResearch/status/1944861086592720998)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BalaBioResearch Avatar BalaBio Research @BalaBioResearch on x XXX followers Created: 2025-07-14 20:46:31 UTC

$FOLD Hard to believe Amicus isn't an acquisition target at these prices. $SNY $BMRN make sense as possible targets, though BMRN would need to leverage with debt. Unless they terribly botch their launches Amicus really should be an easy XX% to XXX% gain in the coming years

XXX engagements

Engagements Line Chart

Related Topics debt $sny acquisition $fold sanofi stocks healthcare $bmrn

Post Link

post/tweet::1944861086592720998
/post/tweet::1944861086592720998